• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Multidimensional predictive model of survival risk in small cell lung cancer patients: A comprehensive analysis based on clinical characteristics and treatment strategies.

作者信息

Deng Yi, Zhang Xin

机构信息

Department of Respiratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.

Department of Respiratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.

出版信息

Curr Probl Surg. 2025 May;66:101759. doi: 10.1016/j.cpsurg.2025.101759. Epub 2025 Mar 28.

DOI:10.1016/j.cpsurg.2025.101759
PMID:40306865
Abstract
摘要

相似文献

1
Multidimensional predictive model of survival risk in small cell lung cancer patients: A comprehensive analysis based on clinical characteristics and treatment strategies.小细胞肺癌患者生存风险的多维预测模型：基于临床特征和治疗策略的综合分析
Curr Probl Surg. 2025 May;66:101759. doi: 10.1016/j.cpsurg.2025.101759. Epub 2025 Mar 28.
2
Construction of a prognostic model for extensive-stage small cell lung cancer patients undergoing immune therapy in northernmost China and prediction of treatment efficacy based on response status at different time points.构建中国最北部广泛期小细胞肺癌患者接受免疫治疗的预后模型，并基于不同时间点的反应状态预测治疗效果。
J Cancer Res Clin Oncol. 2024 May 15;150(5):255. doi: 10.1007/s00432-024-05767-6.
3
Classification of multiple primary lung cancer in patients with multifocal lung cancer: assessment of a machine learning approach using multidimensional genomic data.多灶性肺癌患者中多原发性肺癌的分类：使用多维基因组数据的机器学习方法评估
Front Oncol. 2024 May 3;14:1388575. doi: 10.3389/fonc.2024.1388575. eCollection 2024.
4
Risk stratification and overall survival prediction in extensive stage small cell lung cancer after chemotherapy with immunotherapy based on CT radiomics.免疫治疗联合化疗后广泛期小细胞肺癌 CT 影像组学的风险分层和总生存预测。
Sci Rep. 2024 Sep 30;14(1):22659. doi: 10.1038/s41598-024-73331-w.
5
Association of ERCC1-C118T and -C8092A polymorphisms with lung cancer risk and survival of advanced-stage non-small cell lung cancer patients receiving platinum-based chemotherapy: a pooled analysis based on 39 reports.ERCC1-C118T 和 -C8092A 多态性与接受铂类化疗的晚期非小细胞肺癌患者的肺癌风险和生存的关联：基于 39 份报告的汇总分析。
Gene. 2013 Sep 10;526(2):265-74. doi: 10.1016/j.gene.2013.05.021. Epub 2013 May 30.
6
Response to chemotherapy has predictive value for further survival of patients with advanced non-small cell lung cancer: 10 years experience of the European Lung Cancer Working Party.化疗反应对晚期非小细胞肺癌患者的进一步生存具有预测价值：欧洲肺癌工作组的10年经验
Eur J Cancer. 1997 Dec;33(14):2326-32. doi: 10.1016/s0959-8049(97)00325-0.
7
Epidermal Growth Factor Receptor Mutation (EGFR) Testing for Prediction of Response to EGFR-Targeting Tyrosine Kinase Inhibitor (TKI) Drugs in Patients with Advanced Non-Small-Cell Lung Cancer: An Evidence-Based Analysis.表皮生长因子受体突变（EGFR）检测对晚期非小细胞肺癌患者使用表皮生长因子受体靶向酪氨酸激酶抑制剂（TKI）药物疗效的预测：一项循证分析
Ont Health Technol Assess Ser. 2010;10(24):1-48. Epub 2010 Dec 1.
8
Molecular characterization of clinical responses to PD-1/PD-L1 inhibitors in non-small cell lung cancer: Predictive value of multidimensional immunomarker detection for the efficacy of PD-1 inhibitors in Chinese patients.PD-1/PD-L1 抑制剂治疗非小细胞肺癌的临床反应的分子特征：多维免疫标志物检测对中国患者 PD-1 抑制剂疗效的预测价值。
Thorac Cancer. 2019 May;10(5):1303-1309. doi: 10.1111/1759-7714.13078. Epub 2019 Apr 23.
9
[Peripheral Blood Inflammation Indicators as Predictive Indicators in 
Immunotherapy of Advanced Non-small Cell Lung Cancer].[外周血炎症指标作为晚期非小细胞肺癌免疫治疗的预测指标]
Zhongguo Fei Ai Za Zhi. 2021 Sep 20;24(9):632-645. doi: 10.3779/j.issn.1009-3419.2021.103.10. Epub 2021 Sep 15.
10
Construction and analysis of a lysosome-dependent cell death score-based prediction model for non-small cell lung cancer.基于溶酶体依赖性细胞死亡评分的非小细胞肺癌预测模型的构建与分析
Discov Oncol. 2024 Aug 30;15(1):388. doi: 10.1007/s12672-024-01233-4.

引用本文的文献

1
Cholesterol metabolism shapes immune low-response states in LUAD: a multi-omics cholesterol metabolism signature predicts immunotherapy benefit and identifies DHCR7 as a therapeutic target.胆固醇代谢塑造了肺腺癌中的免疫低反应状态：一种多组学胆固醇代谢特征可预测免疫治疗疗效并将7-脱氢胆固醇还原酶鉴定为治疗靶点。
Front Immunol. 2025 Oct 30;16:1696360. doi: 10.3389/fimmu.2025.1696360. eCollection 2025.